what does venus remedies do

Venus Remedies Limited is a research-based pharmaceutical company specializing in the development, manufacturing, and marketing of injectable solutions and other pharmaceutical products, with a focus on areas like antimicrobial resistance and oncology, and a global presence in over 90 countries.

what products does venus remedies make

Venus Remedies Limited manufactures injectable solutions, analgesics, antipyretics, antibiotics, and engages in the research and development of solutions for antimicrobial resistance and oncology, while also focusing on other therapeutic areas.

what sector is venus remedies in

Venus Remedies Limited operates in the pharmaceutical sector, specifically as a research-driven company involved in the development, manufacturing, and distribution of pharmaceutical products globally.

when was venus remedies founded

Venus Remedies Limited was incorporated in 1989, establishing itself as a key player in the pharmaceutical industry with a focus on injectable formulations and research-based solutions.

who owns venus remedies

Venus Remedies Limited is owned by its shareholders, with the company being a publicly listed entity on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) in India, and it operates as a subsidiary or part of the broader pharmaceutical industry structure.

Venus Remedies Limited (VENUSREM) Share Price Today — ₹1,023

Venus Remedies Limited (VENUSREM) live stock price is ₹1,023 with a change of -1.62% today. Listed on NSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Venus Remedies Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Venus Remedies Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

VENUSREM

NSEBSE

Venus Remedies Limited

Healthcare· Pharmaceuticals & Biotechnology· INE411B01019· Scrip: 526953

EN हिन्दी ગુજરાતી मराठी

₹1,023.00

▼ 16.85 (-1.62%)

20/4/2026, 10:29:40 pm

NSE

₹1,023.00

▼ 16.85

-1.62%

BSE

₹1,022.75

▲ 3.05

+0.00%

244 trading days · 1Y period

TODAY 

Open1,030.00

High1,078.00

Low1,011.35

Prev Close1,039.85

Volume1.34Cr

Value₹0.3Cr

L: 1,011.35H: 1,078.00

52 WEEK

Low₹294.15

High₹1,088.80

92% of 52W range

Info

Face Value₹10

Listed2006-12-20

ISININE411B01019

SeriesB

BSE Scrip526953

Key Metrics

1D

+3.51%

1W

-3.35%

1M

+11.52%

3M

+33.02%

6M

+113.78%

Valuation

P/E (TTM)37.06

P/E (Qtr Ann.)16.47

P/Sales1.86

Mkt Cap₹1209 Cr

Growth (QoQ)

Revenue+5.62%

PAT+457.61%

EPS+457.41%

Profitability

EBITDA Margin17.1%

Net Margin11.1%

TTM EBITDA M.12.7%

TTM Net M.5.4%

Dividend

Yield0.31%

Latest DPS₹3

Payout Ratio20.5%

Growth+0.00%

TTM Revenue

₹648 Cr

TTM EBITDA

₹82 Cr

TTM PAT

₹35 Cr

TTM EPS

₹26.07

Rev/Share

₹484.8

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	177 Cr	164 Cr	30 Cr	25 Cr	20 Cr	₹14.66
2024-09-30	167 Cr	169 Cr	15 Cr	9 Cr	4 Cr	₹2.63
2024-06-30	109 Cr	103 Cr	13 Cr	7 Cr	1 Cr	₹0.92
2024-03-31	195 Cr	182 Cr	23 Cr	17 Cr	11 Cr	₹7.86
2023-12-31	143 Cr	138 Cr	14 Cr	8 Cr	7 Cr	₹5.13
2023-09-30	168 Cr	156 Cr	21 Cr	14 Cr	10 Cr	₹7.44
2023-03-31	156 Cr	139 Cr	28 Cr	20 Cr	11 Cr	₹8.27
2022-12-31	117 Cr	116 Cr	12 Cr	5 Cr	3 Cr	₹2.46

Shareholding Pattern

CURRENT — 2026-03-31

Promoter41.8%

FII2.8%

DII1.2%

Public58.2%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2024-09-13	Other	Annual General Meeting
2023-08-17	Other	Annual General Meeting
2022-08-11	Other	Annual General Meeting
2021-09-09	Other	Annual General Meeting
2020-11-24	Other	Annual General Meeting
2019-09-20	Other	Annual General Meeting
2018-09-14	Other	Annual General Meeting
2017-09-21	Other	Annual General Meeting
2016-09-20	Other	Annual General Meeting
2015-08-17	Other	Annual General Meeting
2014-12-19	Other	Annual General Meeting
2013-09-23	Dividend	Annual General Meeting / Dividend - Rs 3/- Per Share
2012-09-20	Dividend	Annual General Meeting / Dividend Rs. 3/- Per Share
2011-09-22	Dividend	Annual General Meeting And Dividend Rs.3/- Per Share
2010-09-23	Dividend	Annual General Meeting And Dividend Rs.3/- Per Share
2009-09-17	Other	Agm/Div-Rs.3/- Per Share
2008-09-12	Dividend	Agm/Dividend - 40%
2007-09-18	Dividend	Agm/Dividend-30%

Price History

Date	Open	High	Low	Close	Volume
2026-04-30	933.45	975.00	923.45	967.40	40,239
2026-04-29	920.00	949.95	909.95	933.30	54,503
2026-04-28	959.95	959.95	905.20	912.20	44,493
2026-04-27	908.40	982.15	902.15	937.30	1.70L
2026-04-24	967.00	984.75	949.60	949.60	83,694
2026-04-23	1,057.00	1,057.00	999.55	999.55	81,662
2026-04-22	1,038.00	1,059.00	991.00	1,052.15	64,706
2026-04-21	1,022.00	1,069.00	1,020.00	1,024.00	31,845
2026-04-20	1,030.00	1,078.00	1,011.35	1,022.85	55,585
2026-04-17	1,055.55	1,083.00	1,033.90	1,039.85	27,959
2026-04-16	1,072.00	1,081.25	1,026.90	1,039.55	56,016
2026-04-15	1,078.00	1,088.80	1,046.05	1,069.05	79,018
2026-04-13	980.00	1,043.80	975.10	1,040.15	72,945
2026-04-10	998.00	1,025.75	965.25	994.10	1.04L
2026-04-09	1,008.00	1,009.15	962.00	976.95	1.33L
2026-04-08	939.05	961.10	935.00	961.10	30,669
2026-04-07	927.00	939.95	907.60	915.35	31,155
2026-04-02	833.60	904.10	831.10	896.60	94,779
2026-04-01	859.00	861.05	832.05	861.05	17,138
2026-03-27	884.95	884.95	843.05	862.75	46,622
2026-03-25	888.00	909.55	872.20	878.45	56,356
2026-03-24	830.00	866.25	819.20	866.25	40,894
2026-03-20	860.95	898.15	860.95	868.25	37,741
2026-03-19	884.00	917.55	850.10	855.40	44,712
2026-03-18	935.00	937.00	869.20	894.80	52,716
2026-03-17	928.00	928.00	907.50	914.90	30,938
2026-03-16	900.00	939.00	880.10	911.75	72,676
2026-03-13	935.00	944.75	881.15	894.45	78,438
2026-03-12	872.95	940.00	867.70	927.50	2.11L
2026-03-11	783.40	861.70	779.05	861.70	1.12L

Frequently Asked Questions

About

Venus Remedies Limited, incorporated in 1989, is a research-driven Indian pharmaceutical company with a global presence, specializing in injectable products. Known for its focus on critical care and injectables, the company aims to create a positive impact on human health through innovation and research. It has a significant institutional shareholder base and operates in both domestic and international markets.

BOARD OF DIRECTORS

Pravindra Singh Chauhan

Independent Director

DEPARTED

Rupinder Tewari

Independent Director

DEPARTED

I. Machine-readable